Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy-Reference-Cited by-同舟云学术

Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy

Published:2017-01-10 Issue:2 Volume:135 Page:201-203
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Golwala Harsh¹,Bajaj Navkaranbir Singh¹,Arora Garima¹,Arora Pankaj¹

Affiliation:

1. From Brigham and Women’s Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.026056

Reference5 articles.

1. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction

2. Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy

3. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

4. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

5. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy;Heart Failure Clinics;2024-10

2. Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy;J CARDIOL;2024

3. Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy;Journal of Cardiology;2024-09

4. Enhancing patient acceptance of ICD implantation through structured shared decision making: conversation is key;Journal of Interventional Cardiac Electrophysiology;2024-07-13

5. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias;Scientific Reports;2024-06-27